The increasing prevalence of autoimmune kidney disorders is contributing to growing interest in EXT1 antibodies. Autoimmune diseases affecting the kidneys can cause inflammation, tissue damage, and progressive deterioration of renal function. The need for improved diagnostic approaches is encouraging researchers and healthcare professionals to investigate disease-associated biomarkers,...